Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Cancer Genetics Inc (NASDAQ: CGIX)

$4.00 USD $0.00 (0.00%)
Last Price $4
Net Change $0 (0%)
Bid $0
Ask Price $0
Open Price $4
Previous Close Price $4
High Price $4
Low Price $3.86
Number of Trades 413
Volume 104,164
Fifty Two Week High $5.3 (2017-03-27)
Fifty Two Week Low $1.1 (2016-11-04)
Average Daily Volume 398,258
Share Outstanding 19,760 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.11 (2017-05-11)
2nd Quarter Earnings $-0.15 (2017-03-23)
3nd Quarter Earnings $-0.23 (2016-11-10)
4th Quarter Earnings $-0.28 (2016-08-09)
PE Ratio $0
EPS Growth $14
Recent Earnings $-0.11
Annual EPS $-0.77
Last Quarter EPS $
Market Capitalization $0.08B
Insider Shareholders % 0.213%
Annual Revenue $0B
No. Shares Outstanding 19,760
Inst. Shareholder % 12.74%
Annual Net Income $-0.02B
TTM Net Profit Margin $-72.06
1-Year Return 86.92%
3-Year Return -65.1%
5-Year Return -64.44%
5-Year Revenue Growth 798.67%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 14%
Dividends per Share $
Stock Split Ratio
Beta 1.25
Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also offers non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. Cancer Genetics, Inc. is headquartered in Rutherford, New Jersey.

CGIX News & Stock Updates